Madhu Budhraja
Endocrinology, Diabetes & Metabolism · Little Rock, ARNPI 1568517456
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $25,300 of the $28,634 with a category attached, or 88.4%. 14 manufacturers reported payments, led by AstraZeneca at 51.4% of the total. Reporting peaked in 2019 at $25,001 and has fallen 97.7% since, to $583 in 2025.
Across 81 payments — averaging $353.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$15K
- Merck$12K
- Amgen$452
- Johnson & Johnson$363
- AbbVie$282
- Lilly USA, LLC$176
- plus $668 from 8 others
Across 67 payments — averaging $6454.42 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$233K
- Pfizer$197K
- GSK$2K
What the payments were for
- Speaking & faculty fees$25,30088%
- Travel & lodging$4562%
- Food & beverage$2,83810%
- Education$390%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 26 | $14,728 |
| Merck | 15 | $11,965 |
| Amgen | 4 | $452 |
| Johnson & Johnson | 9 | $363 |
| AbbVie | 11 | $282 |
| Lilly USA, LLC | 4 | $176 |
| UCB, Inc. | 1 | $147 |
| Novo Nordisk | 2 | $124 |
| Medtronic | 2 | $115 |
| Amarin Pharma, Inc. | 1 | $111 |
| Sanofi-aventis U.S. LLC | 1 | $97 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $39 |
| Corcept Therapeutics | 1 | $23 |
| Shire North American Group Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$28,634 in reported general payments places this provider in the 70th percentile of 43 endocrinology, diabetes & metabolism providers in Arkansas.
See all endocrinology, diabetes & metabolism providers in Arkansas →
Other endocrinology, diabetes & metabolism in Little Rock
- Richard GriffithsLittle Rock$925K
- James ThrasherLittle Rock$349K
- Richard RappLittle Rock$47K
- Shunzhong BaoLittle Rock$40K
- Teresa NimmoLittle Rock$29K
- Joseph HenskeLittle Rock$23K
- Nidhi JainLittle Rock$9K
- Archana JarathiLittle Rock$7K
- Allen ReddingLittle Rock$7K
- Zulekha HamidLittle Rock$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.